We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisory Panel OKs Post-Partum Depression Treatment
FDA Advisory Panel OKs Post-Partum Depression Treatment
A joint FDA advisory committee Friday voted in favor of the effectiveness, safety and risk-benefit profile of Sage Therapeutics’ NDA for the treatment of post-partum depression.